Send to

Choose Destination
Ann Transl Med. 2015 May;3(Suppl 1):S37. doi: 10.3978/j.issn.2305-5839.2015.03.65.

Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Author information

1 Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden ; 2 Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden ; 3 Division of Infection and Immunity, University College London, and National Institute of Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center